Cumberland Pharmaceuticals (CPIX) Reports Q1 EPS of $0.16

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of $0.16. Revenue for the quarter came in at $11.7 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• Credo Technology Group Holding (CRDO) Tops Q1 EPS by 4c; offers guidance
• General Electric wins $2.9B Navy engine contract from DoD